Skip to content
ProPublica Donate
ProPublica Donate

Bill & Melinda Gates Medical Research Institute

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Health — General and Rehabilitative / Research Institutes and/or Public Policy Analysis (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2023 tax filing, this nonprofit:

Provided first-class or charter travel
Organization provided first-class or charter travel to key employees or officers. Details are reported on Schedule J.

Summary charts: organization finances over time

Revenue
$809M (2023)

Expenses
$190M (2023)

Total Assets
$817M (2023)

Total Liabilities
$62M (2023)

Source: Form 990 tax filings from 2017 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$809,459,647
Expenses
$189,613,154
Net Income
$619,846,493
Net Assets
$755,003,448
Notable Sources of Revenue Percent of Total Revenue
Contributions $809,272,816
100.0%
Program Services $0
Investment Income $183,048
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $3,783
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $5,025,205
2.7%
Professional Fundraising Fees $0
Other Salaries and Wages $38,828,926
20.5%
Assets/Debt
Total Assets $816,974,806
Total Liabilities $61,971,358
Net Assets $755,003,448
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Emilio Emini (Chief Executive Officer) $825,711 $0 $74,069
Michael Dunne (Chief Medical Officer, Head Of Development) $763,134 $0 $92,474
Debra Weiss (Chief Operating Officer) $629,417 $0 $77,773
Piper Trelstad (Head Of Chemistry, Manufacturing & Controls) $589,718 $0 $88,698
Mahendra Pattni (Treasurer (End 11/28/2023)) $535,156 $0 $89,346
Jared Silverman (Head Of Translational Discovery) $509,658 $0 $90,628
James Huleatt (Bioassay Development Lead) $497,303 $0 $85,390
Charles Wells (Head Of Therapeutics Development) $496,164 $0 $76,056
Alexander Schmidt (Head Of Vaccine Development) $479,216 $0 $90,501
Luisa Stamm (Clinical Development Leader) $463,616 $0 $86,031
Marla Curran (Head Of Biostatistics & Data Science) $462,582 $0 $91,298
Sally Jennings (Secretary) $426,910 $0 $81,699
Taryn Rogalski Salter (Head Of Global Regulatory Strategy) $351,238 $0 $48,423
Harish Kaushal (Treasurer (Start 11/28/2023)) $127,240 $0 $23,575
Trevor Mundel (Director, Board Chair) $0 $1,349,206 $75,958
Carolyn Ainslie (Director) $0 $976,547 $78,876
Toni Hoover (Director) $0 $588,080 $78,033
Gagandeep Kang (Director (Start 10/18/2023)) $0 $427,636 $60,196
Helene Madonick (Director) $0 $983 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$12,321,803
Expenses
$137,217,184
Net Income
-$124,895,381
Net Assets
$135,156,955
Notable Sources of Revenue Percent of Total Revenue
Contributions $12,245,754
99.4%
Program Services $0
Investment Income $58,534
0.5%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $17,515
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,001,901
2.9%
Professional Fundraising Fees $0
Other Salaries and Wages $28,758,306
21.0%
Assets/Debt
Total Assets $186,459,426
Total Liabilities $51,302,471
Net Assets $135,156,955
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Emilio Emini (Chief Executive Officer) $778,982 $0 $70,056
Michael Dunne (Chief Medical Officer, Head Of Dev.) $725,742 $0 $87,774
Debra Weiss (Chief Operating Officer) $585,274 $0 $71,664
Piper Trelstadstart 1322 (Head Of Chem, Mfg, Control) $565,246 $0 $84,218
Lee Bansil (Head Of Global Strategic Communications) $538,738 $0 $83,665
Jared Silvermanend 123121 (Head Of Translational Discovery) $487,966 $0 $86,684
Charles Wells (Head Of Therapeutics Development) $485,103 $0 $71,888
Antonio Gonzalez Lopez (Clinical Development Leader) $477,427 $0 $71,992
Alexander Schmidt (Head Of Vaccine Development) $471,658 $0 $84,570
Taryn Rogalski Salter (Head Of Global Reg Strat(end 1/3/22)) $465,694 $0 $74,632
Janie Parrino (Clinical Development Leader) $461,406 $0 $58,970
Mahendra Pattni (Treasurer) $448,355 $0 $83,975
Sally Jennings (Secretary) $416,831 $0 $83,783
Mary Thistle End 42922 (Former Treasurer, Chief Of Staff) $78,357 $0 $18,749
Trevor Mundel (Director, Board Chair) $0 $1,249,224 $72,659
Carolyn Ainslie (Director) $0 $879,108 $74,725
Toni Hoover (Director) $0 $572,338 $73,105
Helene Madonick (Director) $0 $32,038 $0
Susan Desmond Hellmann (Director (End 12/31/22)) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$216,748,532
Expenses
$105,126,022
Net Income
$111,622,510
Net Assets
$260,067,335
Notable Sources of Revenue Percent of Total Revenue
Contributions $216,721,752
100.0%
Program Services $0
Investment Income $16,207
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $10,573
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,680,294
4.5%
Professional Fundraising Fees $0
Other Salaries and Wages $21,710,985
20.7%
Assets/Debt
Total Assets $277,647,725
Total Liabilities $17,580,390
Net Assets $260,067,335
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Michael Dunne (Chief Medical Officer(start 12/2020)) $716,407 $0 $85,046
Debra Weiss (Chief Operating Officer) $530,549 $0 $68,856
Penny Heaton (Ceo (End 7/2021)) $479,111 $0 $59,546
Jared Silverman (Head Of Translational Discov) $471,105 $0 $84,368
Charles Wells (Clinical Development Leader) $458,931 $0 $69,601
Mohamed Bassyouni (Product Development Program Leader) $446,774 $0 $81,098
Taryn Rogalski Salter (Head Of Global Reg Strat (Start 5/2021)) $443,020 $0 $72,328
Alexander Schmidt (Clinical Development Leader) $439,571 $0 $82,709
David Holtzman (Clinical Development Leader) $421,594 $0 $80,123
Yvonne Wolf End 12021 (Head Of Human Resources) $404,441 $0 $2,714
Sally Jennings (Secretary) $402,940 $0 $81,446
Mahendra Pattni (Treasurer (Start 5/2021)) $311,585 $0 $67,544
Emilio Emini (Director,Ceo(end 7/2021;Start 8/2021)) $309,872 $351,349 $70,443
Mary Thistle (Treasurer (End 5/2021)) $234,484 $0 $58,135
Dina Berdieva (Head Of Prjt Mgmt, Clinical Ops) $198,919 $0 $0
Jorg Thommes (Head Of Chem, Mfg, Control (End 5/2021)) $154,056 $0 $36,827
Carolyn Ainslie (Director) $0 $813,961 $80,263
Helene Madonick (Director) $0 $27,450 $0
Susan Desmond Hellmann (Director) $0 $0 $0
Toni Hoover (Director (Start 7/2021)) $0 $553,057 $70,846
Trevor Mundel (Director, Board Chair) $0 $1,162,609 $70,401

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$32,100,737
Expenses
$99,371,314
Net Income
-$67,270,577
Net Assets
$148,429,825
Notable Sources of Revenue Percent of Total Revenue
Contributions $31,990,419
99.7%
Program Services $0
Investment Income $110,318
0.3%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $4,401,215
4.4%
Professional Fundraising Fees $0
Other Salaries and Wages $19,441,624
19.6%
Assets/Debt
Total Assets $171,367,184
Total Liabilities $22,937,359
Net Assets $148,429,825
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Penny Heaton (Chief Executive Officer) $805,524 $0 $69,399
Monicah Otieno (Head Of Nonclinical Develop) $493,061 $0 $77,608
Charles Wells (Head Of Therapeutics Development) $450,447 $0 $67,766
Mary Thistle (Treasurer) $449,600 $0 $67,790
Jared Silverman (Head Of Translational Discov) $447,904 $0 $81,892
Debra Weiss (Head Of Qual Assur And Ops) $447,568 $0 $66,652
Taryn Rogalski Salter (Head Of Global Reg Strategy) $436,655 $0 $70,479
Alexander Schmidt (Head Of Vaccine Development) $431,488 $0 $79,695
Jorg Thommes (Head Of Chem, Manu, Controls) $430,862 $0 $79,229
David Kaufman End 2122020 (Head Of Translational Development) $418,457 $0 $70,671
Sally Jennings (Secretary) $413,402 $0 $79,597
Jintanat Ananworanich (Clinical Development Leader) $412,788 $0 $79,431
Dina Berdieva End 12042020 (Head Of Prj Mgmt, Clinical Ops) $387,641 $0 $283,949
Trevor Mundel (Director, Board Chair) $0 $1,137,035 $80,764
Carolyn Ainslie Start 432020 (Director) $0 $762,493 $80,403
Helene Madonick (Director) $0 $680,655 $52,814
Emilio Emini (Director) $0 $559,237 $67,297
Susan Desmond Hellmann (Director) $0 $339,358 $39,651
Andrew Farnum End 432020 (Director) $0 $118,416 $22,461

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$9,807,864
Expenses
$41,227,552
Net Income
-$31,419,688
Net Assets
$215,700,402
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,254,862
94.4%
Program Services $0
Investment Income $545,619
5.6%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $7,383
0.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $4,567,523
11.1%
Professional Fundraising Fees $0
Other Salaries and Wages $14,002,264
34.0%
Assets/Debt
Total Assets $219,318,998
Total Liabilities $3,618,596
Net Assets $215,700,402
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Penny Heaton (Chief Executive Officer) $773,468 $0 $65,887
David Kaufman (Head Of Translational Development) $566,324 $0 $76,335
Helen Boudreau End 812019 (Secretary & Treasurer) $484,905 $0 $60,253
Taryn Rogalski Salter (Head Of Regulatory Affairs) $468,311 $0 $68,207
Jeffrey Barret (Head Of Quant. Sciences) $456,323 $0 $76,224
Mary Thistle Start 812019 (Treasurer) $454,784 $0 $65,568
Jorg Thommes (Head Of Chem, Mfg & Controls) $446,244 $0 $76,224
Russell Weiner (Biomarker Assay Development Leader) $438,231 $0 $66,387
Alexander Schmidt (Clinical Development Leader) $430,566 $0 $78,692
Dina Berdieva (Head Of Proj. Mgmt. & Clin) $428,665 $0 $83,842
Debra Weiss (Head Of Quality Assurance) $427,306 $0 $69,484
Jared Silverman (Head Of Translational Discovery) $415,128 $0 $78,557
Sally Jennings Start 812019 (Secretary) $413,243 $0 $78,097
Susan Desmond Hellmann (Director) $0 $1,461,692 $67,612
Trevor Mundel (Director, Board Chair) $0 $1,089,701 $78,684
Helene Madonick (Director) $0 $733,051 $76,323
Emilio Emini (Director) $0 $541,573 $65,986
Andrew Farnum (Director) $0 $416,794 $56,530

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$9,822,484
Expenses
$22,373,638
Net Income
-$12,551,154
Net Assets
$247,120,090
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,622,298
98.0%
Program Services $0
Investment Income $200,186
2.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $1,499,296
6.7%
Professional Fundraising Fees $0
Other Salaries and Wages $8,480,062
37.9%
Assets/Debt
Total Assets $248,840,285
Total Liabilities $1,720,195
Net Assets $247,120,090
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
David Kaufman (Chief Medical Officer) $923,536 $0 $73,410
Penny Heaton (Chief Executive Officer) $705,713 $0 $63,782
Debra Weiss (Head Of Quality Assurance) $510,402 $0 $65,606
Mary Thistle (Chief Of Staff) $431,087 $0 $73,409
Jeff Barrett (Head Of Quantitative Sciences) $415,962 $0 $65,337
Dina Berdieva (Head Of Proj. Mgmt. & Clinical Ops) $408,953 $0 $61,016
Sally Jennings (Head Of Compliance & Risk Management) $322,680 $0 $71,163
Helen Boudreau Start 6112018 (Secretary & Treasurer) $276,250 $0 $59,708
Jim Bromley End 682018 (Director, Secretary & Treasurer) $0 $254,464 $53,857
Susan Desmond Hellmann (Director) $0 $1,424,916 $64,862
Emilio Emini (Director) $0 $515,959 $63,400
Andrew Farnum Start 5222018 (Director) $0 $232,157 $34,059
Helene Madonick (Director) $0 $785,879 $82,282
Trevor Mundel (Director, Board Chair) $0 $1,063,792 $74,571

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$262,698,758
Expenses
$3,027,514
Net Income
$259,671,244
Net Assets
$259,671,244
Notable Sources of Revenue Percent of Total Revenue
Contributions $262,692,744
100.0%
Program Services $0
Investment Income $6,014
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $0
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $0
Professional Fundraising Fees $0
Other Salaries and Wages $0
Assets/Debt
Total Assets $259,671,244
Total Liabilities $0
Net Assets $259,671,244
Compensation
Key Employees and Officers Compensation Related Other
Susan Desmond Hellmann (Director) $0 $869,983 $13,637
Jim Bromley (Director, Secretary And Treasurer) $0 $334,292 $38,295
Trevor Mundel (Director) $0 $612,767 $21,676
Emilio Emini (Director) $0 $275,958 $39,223
Helene Madonick (Director) $0 $569,348 $43,978
Penny Heaton (Chief Executive Officer) $0 $317,056 $36,538

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »